Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Stem cell therapy can be used for LSCD, reports newly published research

Newly published research, by investigators, at the North East England Stem Cell Institute (NESCI) in the journal Stem Cells reported the first successful treatment of eight patients with "Limbal Stem Cell Deficiency" (LSCD) using the patients' own stem cells without the need of suppressing their immunity.

11 Dec 2009

Senior research scientist to receive 2009 Astellas USA Foundation Award

Fredrick Khachik, Ph.D., a senior research scientist in the Department of Chemistry and Biochemistry at the University of Maryland, College Park, has been chosen to receive a 2009 Astellas USA Foundation Award.

11 Dec 2009

Research study shows usage of stem cell-based therapies for treating age-related macular degeneration

An international team of scientists has rescued visual function in laboratory rats with eye disease by using cells similar to stem cells. The research shows the potential for stem cell-based therapies to treat age-related macular degeneration in humans.

4 Dec 2009

Macular Health eye vitamin supplement improves visual acuity

Adults are more likely to lose their vision than be diagnosed with cancer. For adults 65 and over, the odds of losing vision are one in three, whereas the odds of a man developing prostate cancer are one in six and odds of a woman developing breast cancer are one in nine. Vision loss threatens the overall health of aging adults by increasing the risk of injuries, depression and inability to complete daily tasks.

3 Dec 2009

UGR scientists provide early diagnosis of eye disorders through optical technique

Researchers from the University of Granada have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

26 Nov 2009

UGR researchers provide early diagnosis of ARMD and keratitis

Researchers from the UGR have provided an early diagnosis of certain ocular diseases that are very common today, such as age-related macular degeneration and keratitis, by applying an existing optical technique that, nevertheless, had never before been used for this purpose.

25 Nov 2009

Smoothie Factory supports Chronic Disease Fund’s mission with holiday fundraising program

More than 14-million Americans, with chronic or life altering diseases and cancer, can’t afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That’s why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.

25 Nov 2009

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

StemCells, Inc. announced today that it has commenced patient recruitment for a Phase I clinical trial designed to test the safety and preliminary efficacy of its HuCNS-SC® purified human neural stem cells in Pelizaeus-Merzbacher Disease (PMD), a neurological disorder that primarily afflicts children. The study is being conducted at the University of California, San Francisco (UCSF) Children’s Hospital, one of the leading medical centers in the United States for neonatology, pediatric neurology and neurosurgery.

24 Nov 2009

Acucela to present data on its ACU-4429 visual cycle modulator for dry AMD

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data for the company’s novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular degeneration (dry AMD), will be featured at the 8th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) being held in Rome, Italy from December 3 to 6, 2009.

23 Nov 2009

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.

19 Nov 2009

ISCO, Scripps Research Institute collaborate in study of parthenogenetic stem cells

International Stem Cell Corporation, announced today that it is collaborating with renowned stem cell researcher Jeanne F. Loring, Ph.D., and the Scripps Research Institute (La Jolla, CA) to study parthenogenetic stem cells and potentially therapeutic cells that can be derived from them.

19 Nov 2009

SoloHealth and Kroger stores team up to promote eye health awareness

SoloHealth (www.solo-health.com), maker of EyeSite™ self-service vision testing and self-directed healthcare kiosks, has teamed with Atlanta area Kroger stores to promote eye health awareness and to encourage regular eye exams.

19 Nov 2009

AMD: A leading cause of blindness among smokers

MD Alliance International strongly urges all smokers to participate in the Great American Smokeout on November 19 to save their eyes and protect their vision from the debilitating effects of macular degeneration.

18 Nov 2009

Determining the cause for death of photoreceptors could hold the key to stopping blinding disorders

Determining what triggers the death of retinal cells, called photoreceptors, could hold the key to stopping blinding disorders caused by a wide range of eye diseases, Yale School of Medicine researchers report in the November journal Investigative Ophthalmology & Visual Science.

16 Nov 2009

Novadaq announces financial results for the third quarter of 2009

Novadaq® Technologies Inc., a developer of real-time imaging systems for use in the operating room, today announced 2009 third quarter revenues of $1,723,000 compared to revenue of $3,311,000 in third quarter 2008. In accordance with corporate policy, a previously reported order in excess of $2,000,000 has not been recorded in sales due to cash not yet received.

12 Nov 2009

Plant carotenoids are the most important source of vitamin A in the human diet

Carotenoids-fat-soluble plant compounds found in some vegetables-are essential to the human diet and reportedly offer important health benefits to consumers. Plant carotenoids are the most important source of vitamin A in the human diet; the carotenoids lutein and zeaxanthin, found in corn and leafy greens vegetable such as kale, broccoli, and spinach, are widely considered to be valuable antioxidants capable of protecting humans from chronic diseases including age-related macular degeneration, cancer, and cardiovascular disease.

5 Nov 2009

Reduced VEGF can lead to degeneration of retina

Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).

4 Nov 2009

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Marking a significant bench to bedside research milestone in Singapore, the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, and the National University Hospital (NUH) launched the IBN iCare and the NUH Eye Centre @ Biopolis at an official opening ceremony officiated by the Senior Minister of State for Trade and Industry and Education, S. Iswaran, at the Biopolis on Nov. 3, 2009.

4 Nov 2009

Arrowhead Research updates its shareholders

Arrowhead Research Corporation’s (NASDAQ: ARWR) President and Chief Executive Officer today issued the following letter to the Company’s shareholders.

3 Nov 2009

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

2 Nov 2009

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Stem cell therapy can be used for LSCD, reports newly published research

Senior research scientist to receive 2009 Astellas USA Foundation Award

Research study shows usage of stem cell-based therapies for treating age-related macular degeneration

Macular Health eye vitamin supplement improves visual acuity

UGR scientists provide early diagnosis of eye disorders through optical technique

UGR researchers provide early diagnosis of ARMD and keratitis

Smoothie Factory supports Chronic Disease Fund’s mission with holiday fundraising program

StemCells commences patient recruitment for a Phase I clinical trial of HuCNS-SC in PMD

Acucela to present data on its ACU-4429 visual cycle modulator for dry AMD

Advanced Cell Technology files an IND with the FDA for study using embryonic stem cells to treat SMD

ISCO, Scripps Research Institute collaborate in study of parthenogenetic stem cells

SoloHealth and Kroger stores team up to promote eye health awareness

AMD: A leading cause of blindness among smokers

Determining the cause for death of photoreceptors could hold the key to stopping blinding disorders

Novadaq announces financial results for the third quarter of 2009

Plant carotenoids are the most important source of vitamin A in the human diet

Reduced VEGF can lead to degeneration of retina

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Arrowhead Research updates its shareholders

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in